Alert detail
Proposed LCD DL40407: MolDX: Genome-Wide Molecular Methodologies for the Detection of Copy Number Alterations and Structural Variants in Hematologic Neoplasms — Palmetto GBA
Policy ID: LCD-DL40407Specialty: OncologyAdded: 8/27/2026lcd
What changed
Proposed LCD: Genome-wide CNA/SV testing in blood cancers—comment by 10/11/26
Who’s affected: Oncology billing teams
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 10 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.